| Literature DB >> 28659810 |
Rahim Dad Brohi1,2, Li Wang1,2, Najla Ben Hassine3, Jing Cao1,2, Hira Sajjad Talpur1,2, Di Wu1,2, Chun-Jie Huang1,2, Zia-Ur Rehman1,2, Dinesh Bhattarai1,2, Li-Jun Huo1,2.
Abstract
Mature spermatozoa have highly condensed DNA that is essentially silent both transcriptionally and translationally. Therefore, post translational modifications are very important for regulating sperm motility, morphology, and for male fertility in general. Protein sumoylation was recently demonstrated in human and rodent spermatozoa, with potential consequences for sperm motility and DNA integrity. We examined the expression and localization of small ubiquitin-related modifier-1 (SUMO-1) in the sperm of water buffalo (Bubalus bubalis) using immunofluorescence analysis. We confirmed the expression of SUMO-1 in the acrosome. We further found that SUMO-1 was lost if the acrosome reaction was induced by calcium ionophore A23187. Proteins modified or conjugated by SUMO-1 in water buffalo sperm were pulled down and analyzed by mass spectrometry. Sixty proteins were identified, including proteins important for sperm morphology and motility, such as relaxin receptors and cytoskeletal proteins, including tubulin chains, actins, and dyneins. Forty-six proteins were predicted as potential sumoylation targets. The expression of SUMO-1 in the acrosome region of water buffalo sperm and the identification of potentially SUMOylated proteins important for sperm function implicates sumoylation as a crucial PTM related to sperm function.Entities:
Keywords: Bubalus bubalis; SUMO-1; post translational modification; protein; spermatozoa
Year: 2017 PMID: 28659810 PMCID: PMC5468435 DOI: 10.3389/fphys.2017.00354
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
Figure 1Acrosome identification in buffalo bull sperm and four categories of Buffalo bull sperm acrosome status. (A) (Image a) Coomassie Brilliant Blue staining of sperm with an intact and reacted acrosome, (image b) FITC-PNA stained, (image c) DAPI-stained, (image d) DAPI+FITC-PNA- stained images. (B) (Image a) intact acrosome, (image b) equatorial acrosome region, (image c) post acrosomal region, (image d) reacted acrosome. Scale bar, 20 μm; Magnification, 1,000x.
Figure 2Localization of SUMO-1 in the acrosome of Buffalo bull and mouse spermatozoa. (A) DAPI, for nuclear staining (blue signal), SUMO-1, Anti-SUMO1 antibody followed by a CY3-conjugated secondary antibody (Red fluorescence), Merged, DAPI nuclear staining plus anti-SUMO1 antibody. (B) SUMO1 co-localization and expression in buffalo bull sperm. Collected spermatozoa were stained with SUMO1 antibody pursued by incubation with Cy-3 conjugated goat anti rabbit IgG (color red). The specimen were then restained with 4, 6-diamino-2-phenylindole (DAPI, 1:5,000 in PBS) (blue color) and FITC-PNA (flurescein isothiocyanate-conjugated peanut agglutinin) (green color). In (panel a) the superposed images shown in the spermatozoa were stained with SUMO-1 antibody followed by incubation with Cy-3 conjugated goat anti rabbit IgG. (panel b) the superposed images are shown in negative samples as control. (panel c) the images show both an intact and reacted acrosome, and the disappearance of SUMO-1 in the acrosome-reacted buffalo bull spermatozoa. Note that both SUMO-1 and FITC-PNA disappeared in acrosome region of the acrosome-reacted spermatozoa. The images were observed using a Nikon inverted fluorescence microscope. The scale bar is 100 μm.
Figure 3Expression of SUMO-1 in water buffalo spermatozoa. (A) Western blot analysis of SUMO-1 expression in water buffalo spermatozoa after in vitro capacitation, showing capacitation-induced changes in SUMO-1-modifications in sperm (lane b) compared to non-capacitated sperm (lane a). (B) Western blot analysis of acrosome reacted (lane a) vs. acrosome non-reacted (lane b) water buffalo spermatozoa. (C) Buffalo bull sperm proteins were immunoprecipatated with SUMO-1 antibody, and then run for SDS-PAGE and stained with coomassive brilliant blue. For the negative control (NC). (D) SUMO-1 conjugates were pull down from water buffalo sperm lysates by a SUMO-1 antibody and were analyzed by western blot to detect SUMO-1 expression.
Figure 4SCL in whole cell sperm in Bubalus bubalis. Plot describing the distribution of protein Sub-cellular localization [SCL] predicted by iLoc-Animal and iLoc-Euk tools. [C]: cytoplasm; [C,N]: cytoplasm and nculeus; [C,EC]: cytoplasm and extracellular; [CM,C]: cell membrane and cytoplasm; [C,MT]: cytoplasm and mitochondrion; [C,ED]: cytoplasm and endosome; [C,ER]: cytoplasm and endoplasmic reticulum; [C,N,CK]: cytoplasm, nucleus, cytoskeleton; [C,N,ER,MT]: cell membrane, cytoplasm, endoplasmic reticulum, and mitochondrion; [NA]: No Available results for those sequences.
Figure 5Functional Protein Classification (COGs). (A) Distribution of proteins count in the COGs categories. Colored boxes correspond to the unique COGs subcategories (EggNOG v4.5 terms). (B) The pie shown each COG category percentage.
Figure 6GO analysis. The GO analysis was performed with PANTHER (V11). (A) Details of GO terms distribution. (B) The terms were reclassified using Categorizer [http://animalgenome.org]. This represents the mapping of 22 GO terms to 127 of the “GO Slim” ancestor terms by single count. (C) Plot of GO terms details. Further analysis of GO terms was conducted by Rivgo [http://revigo.irb.hr].
Figure 7Protein-Protein Interaction [STRING-V10.0] (PPIs). The PPI was built using the following parameters: Bos taurus background (No match for Bubalus bubalis found, B.bubalis genome is not full and well-annotated yet). Highest confidence Score = 0.55. The dark line in the graph correspond to Highest confidence score higher than 0.7. Hide disconnected nodes in the network. PPI enrichment p-value = 0.000124, clustering coefficient: 0.902.
Pathways analysis (PANTHER-STRING) Count: Number of genes in the set.
| 1 | Wnt signaling pathway | PANTHER-(v11) | 3 | |
| 2 | Cadherin signaling pathway | PANTHER-(v11) | 2 | |
| 3 | Inflammation mediated by chemokine and cytokine signaling pathway | PANTHER-(v11) | 2 | |
| 4 | Nicotinic acetylcholine receptor signaling pathway | PANTHER-(v11) | 2 | |
| 5 | Phagosome | KEGG(STRING,V10) | 5 | |
| 6 | Gap junction | KEGG(STRING,V10) | 4 | |
| 7 | IPR002452 | Alpha tubulin | InterPro(STRING,V10) | 3 |
| 8 | IPR004001 | Actin, conserved site | InterPro(STRING,V10) | 3 |
| 9 | IPR020902 | Actin/actin-like conserved site | InterPro(STRING,V10) | 3 |
| 10 | IPR000217 | Tubulin | InterPro(STRING,V10) | 3 |
| 11 | IPR003008 | Tubulin/FtsZ, GTPase domain | InterPro(STRING,V10) | 3 |
| 12 | IPR003054 | Keratin, type II | InterPro(STRING,V10) | 3 |
| 13 | IPR008280 | Tubulin/FtsZ, C-terminal | InterPro(STRING,V10) | 3 |
| 14 | IPR017975 | Tubulin, conserved site | InterPro(STRING,V10) | 3 |
| 15 | IPR018316 | Tubulin/FtsZ, 2-layer sandwich domain | InterPro(STRING,V10) | 3 |
| 16 | IPR023123 | Tubulin, C-terminal | InterPro(STRING,V10) | 3 |
| 17 | IPR004000 | Actin family | InterPro(STRING,V10) | 3 |
| 18 | GO.0014902 | Myotube differentiation | GO(STRING,V10) | 3 |
| 19 | GO.0005200 | Structural constituent of cytoskeleton | GO(STRING,V10) | 3 |
| 20 | GO.0005865 | Striated muscle thin filament | GO(STRING,V10) | 3 |
| 21 | GO.0030017 | Sarcomere | GO(STRING,V10) | 4 |
| 22 | GO.0001725 | Stress fiber | GO(STRING,V10) | 3 |
| 23 | GO.0005884 | Actin filament | GO(STRING,V10) | 3 |
| 24 | GO.0030016 | Myofibril | GO(STRING,V10) | 4 |
| 25 | GO.0030175 | Filopodium | GO(STRING,V10) | 3 |
| 26 | GO.0044430 | Cytoskeletal part | GO(STRING,V10) | 7 |
| 27 | GO.0030027 | Lamellipodium | GO(STRING,V10) | 3 |
The table shows pathways with significant value.
Figure 8Distribution of SUMO modification types reported by (GPS-SUMO2.0).
Figure 9Seq2Logo2.0 representation of three types of SUMO modification peptides sequences reported by (GPS-SUMO2.0).
Summary of bio-analysis findings SI, SUMO-Interaction; SNC, Sumoylation Non-Concensus; SC, Sumoylation Concensus. SCL (Ref. Table S2); COG categories (Ref. Figure 2); (*) (Ref. Discussion).
| 1 | Zinc finger protein 668 | 2 | SC | K56 | Consensus inv | CT,N | K | |
| 1.1 | Vinexin | 1 | SI | None | None | – | Cytoplasm | T |
| 1.1 | Vinexin | 3 | SC | K168 | NDSM | |||
| 2 | V(D)J recombination-activating protein 1 | 1 | SC | K56 | None | – | CT,N | L |
| 2.1 | Ubiquitin carboxyl-terminal hydrolase-48 | 1 | SNC | K960 | None | Cytoplasm | O | |
| 2.1 | Ubiquitin carboxyl-terminal hydrolase-48 | 4 | SC | K960 | None | – | ||
| 2.2 | Tumor necrosis factor alpha-induced protein 2 | 1 | SNC | K663 | None | – | Cytoplasm | U |
| 2.2 | Tumor necrosis factor alpha-induced protein 2 | 3 | SC | K663 | Extended PDSM | |||
| G1 | Tubulin alpha-1D chain-like | 1 | SC | K304 | SUMO-Ac switch | – | Cytoplasm | A,Z |
| G2 | Tubulin alpha-1C chain-like | 1 | SC | K230 | SUMO-Ac switch | – | Cytoplasm | A,Z |
| G3 | Tubulin alpha-1B chain | 1 | SC | K304 | SUMO-Ac switch | – | Cytoplasm | A,Z |
| 3 | Tubulin alpha-1A chain-like | 3 | SC | K304 | SUMO-Ac switch | – | CT,N | A,Z |
| 4 | Sterile alpha motif domain-containing protein 15 | 6 | SC | K349 | NDSM | Homo sapiens [RANBP2 (P49792), (Q15326)] | CT,N | S |
| 5 | Sperm-associated antigen 16 protein-like | 1 | SI | CT,N | S,Z | |||
| 6 | SMAD4 | 2 | SC | K159 | NDSM | CT,N | K,T | |
| 7 | SMAD family member 4 | 2 | SC | K159 | NDSM | Cytoplasm | K,KT | |
| 8 | Serum albumin | 3 | SC | K204 | HCSM | Homo sapiens [(Q12948), (P12004)]- | CT,EC | S,U,W |
| 3.1 | Serine/threonine-protein kinase | 1 | SI | AA 52-55 | SIM Type β | Homo sapiens [Fir1 (P40020)]- | CT,N | T |
| Nek5 | ||||||||
| 3.1 | Serine/threonine-protein kinase Nek5 | 1 | SNC | K123 | None | – | ||
| 3.1 | Serine/threonine-protein kinase Nek5 | 3 | SC | K123 | SC-Direct | – | ||
| 9 | Ribonuclease T2 | 1 | SNC | CT,EC | A | |||
| 3.2 | rho GTPase-activating protein 42-like | 1 | SC | K428 | SC-Direct | Cytoplasm | T | |
| 3.2 | rho GTPase-activating protein 42-like | 1 | SI | AA 560-563 | SIM Type β | Cytoplasm | ||
| 3.2 | rho GTPase-activating protein 42-like | 1 | SNC | K428 | SC-Inverted | Cytoplasm | ||
| 10 | Relaxin-3 receptor 2 | 1 | SC | K272 | SC-Direct | – | CM | T |
| 11 | Proteoglycan 3-like | 1 | SC | K300 | SC-Direct | Cytoplasm | TV | |
| 12 | Protein FAM185A | 2 | SC | K300 | SC-Direct | Cytoplasm | S | |
| 13 | Pro-neuregulin-2, membrane-bound isoforms | 3 | SC | K304 | SC-Direct | CM | S,T | |
| 14 | Pregnancy-associated glycoprotein 6 | 2 | SC | CT,EC | O | |||
| 12 | Pregnancy-associated glycoprotein 11 | 1 | SI | AA 13-16 | SIM Type β | Homo sapiens [SETDB1 (Q15047)] | CT,EC | O |
| 12 | Pregnancy-associated glycoprotein 11 | 2 | SC | – | – | – | ||
| 15 | Pregnancy-associated glycoprotein 7 | 3 | SC | Cytoplasm | O | |||
| 16 | Phosphatidylinositol 3-kinase catalytic subunit type 3-like | 5 | SC | K68 | SC-Direct | CT,ED | T | |
| 17 | Outer dense fiber protein 1 | 1 | SC | K197 | SC-Direct | CT,N | Z | |
| 33 | Nucleoprotein TPR | 1 | SNC | K585 | SC-Inverted | CT,N | * | |
| 33 | Nucleoprotein TPR | 3 | SI | AA 456-462 | SIM Type α | |||
| 33 | Nucleoprotein TPR | 7 | SC | K710 | SC-Direct | |||
| 13 | Nuclear receptor coactivator 5 | 1 | SC | AA 226-229 | SIM Type α | Homo sapiens [Arkadia (Q6ZNA4)] | CT,N | K,UY |
| 13 | Nuclear receptor coactivator 5 | 1 | SI | AA 202-205 | SIM Type β | – | ||
| 18 | Nuclear envelope pore membrane protein POM121C | 1 | SC | CT,RE | S,U | |||
| 14 | NFX1-type zinc finger-containing protein 1 | 3 | SI | AA 771-774 | SIM Type α | Homo sapiens [Pc2/CBX4 (000257)] | Cytoplasm | L |
| 14 | NFX1-type zinc finger-containing protein 1 | 5 | SC | K671 | SC-Direct | Homo sapiens (095785) | ||
| 23 | MDS1 and EVII complex locus protein EVII-like | 1 | SNC | K623 | SC-Inverted | – | CT,N | K |
| 23 | MDS1 and EVII complex locus protein EVII-like | 5 | SC | K622 | SC-Direct | – | ||
| 19 | Latent-transforming growth factor beta-binding protein | 1 | SC | K362 | SC-Direct | – | CT,EC | T |
| 25 | Keratin, type II cytoskeletal 5 | 1 | SC | Cytoplasm | S,T,Z | |||
| 25 | Keratin, type II cytoskeletal 5 | 1 | SNC | |||||
| 24 | G patch domain-containing protein 4 | 1 | SC | K138 | SC-Direct | CT,N | A,AD | |
| 24 | G patch domain-containing protein 4 | 1 | SNC | K200 | SC-Inverted | – | ||
| 15 | Filamin-C | 1 | SI | AA 413-416 | SIM Type α | Cytoplasm | ** | |
| 15 | Filamin-C | 6 | SC | K894 | SC-Direct | |||
| 16 | Fibrous sheath-interacting protein 2-like | 3 | SI | AA 906-909 | SIM Type β | CT,N | S | |
| 16 | Fibrous sheath-interacting protein 2-like | 16 | SC | K212 | SC-Direct | |||
| 17 | Dynein heavy chain 2, axonemal | 3 | SI | AA 4266-4269 | SIM Type β | CT,N,EC | Z | |
| 17 | Dynein heavy chain 2, axonemal | 7 | SC | K4232 | SC-Inverted | |||
| 41 | Cadherin EGF LAG seven-pass G-type receptor 2 | 1 | SNC | K2072 | SC-Inverted | CM,CT | U,T,TW | |
| 41 | Cadherin EGF LAG seven-pass G-type receptor 2 | 2 | SI | AA 492-495 | SIM Type 1 | – | ||
| 18 | Cadherin EGF LAG seven-pass G-type receptor 1 | 2 | SC | AA 706-709 | SIM Type 1 | – | CM,CT | U,T,TW |
| 18 | Cadherin EGF LAG seven-pass G-type receptor 1 | 2 | SI | AA 2339-2342 | SIM Type α | |||
| 20 | BCL-6corepressor-like | 2 | SC | AA 447-450 | SIM Type β | – | nucleus | K |
| 21 | ATP-dependent RNA helicase DDX54 | 1 | SC | AA 696-699 | SIM Type 1 | nucleus | A,O | |
| 22 | ADP-ribosyltransferase 4 | 1 | SC | K65 | SC-Direct | CM,CT,RE,MT | G | |
| G2 | Actin, gamma-enteric smooth muscle | 1 | SC | AA 249-251 | SIM Type β | Cytoplasm | Z | |
| G2 | Actin, aortic smooth muscle | 1 | SC | AA 249-252 | SIM Type β | Cytoplasm | Z | |
| G2 | Actin, alpha skeletal muscle | 1 | SC | AA 249-252 | SIM Type β | Cytoplasm | Z | |
| G2 | Actin, alpha cardiac muscle 1 | 1 | SC | AA 249-252 | SIM Type β | Cytoplasm | Z | |
REF, Reference in Discussion Section; PROTEIN NAME, Protein predicted as Sumoylated by GPS-SUMO; COUNT, Number of unique sequences; Type GPS, Type of Sumoylation reported by GPS-SUMO.
POSITION, K (Lysine)/Motif position; Dbhit, Several relevant Uniprot hits reported by JASSA.
Type JASSA, Type of Sumoylation predicted by JASSA (Please check the patterns list at .
SI, SUMO-Interaction; SNC, Sumoylation Non-Concensus; SC, Sumoylation Concensus. SCL, (Ref. Table .
JASSA was launched with the following parameters: Best predictions, Motifs: all types, high-cut-off [PSmax = 38.183 | Cut-off = 2.032].
SIM, SUMO-interacting motifs (SIM).
SUMO, putatifs SUMO site: Consensus direct/indirect.
NDSM, Negatively charged amino acid-dependent SUMOylation site.
PDSM, Phosphorylation-dependent SUMOylation motif.
HCSM, Hydrophobic cluster SUMOylation motif.
Psmax, Maximum Predictive Score; Ps, Predicted score direct; Ps, Predicted score Inverted; SC-Direct, Strong Consensus Direct; SC-Inverted, Strong Consensus Inverted.
White, Protein without isoforms in the list; Light green, Protein with 2 isoforms; Light Yellow, Protein with 3 isoforms; Light Blue, Group 1 and Group 2 mentioned in the text; Dark green, No COG annotation was founded for those proteins.
Figure 10TPR and Filamin-C analysis with [STRING-V10.0]. Protein of interest is marked in Red in the graph. (A) TPR protein-protein interaction network. (Highest confidence Score = 0.9. Hide disconnected nodes in the network. PPI enrichment p-value = 0); (B) Filamin-C, COG analysis. This protein is marked as Non Supervised Orthologous Group (NOG19963) and is below to three edges of the graph with two COGs terms [COG5160 andCOG5079]. (C) COG analysis for TPR protein with string. TPR is marked as Non Supervised Orthologous Group (NOG07190). Two COGs terms are present in the graph [COG5646 andCOG5201].
Nucleoprotein TPR, pathways [STRING-v10] Count: count in gene set.
| 1 | 3013 | RNA transport | KEGG(STRING,V10) | 11 | 8.29E-022 |
| 2 | GO.0051028 | mRNA transport | GO(STRING,V10) | 5 | 2.67E-008 |
| 3 | GO.0006403 | RNA localization | GO(STRING,V10) | 5 | 3.12E-008 |
| 4 | GO.0006999 | Nuclear pore organization | GO(STRING,V10) | 2 | 0.000325 |
| 5 | GO.0006406 | mRNA export from nucleus | GO(STRING,V10) | 2 | 0.0142 |
| 6 | GO.0071427 | mRNA-containing ribonucleoprotein complex export from nucleus | GO(STRING,V10) | 2 | 0.0142 |
| 7 | GO.0071166 | Ribonucleoprotein complex localization | GO(STRING,V10) | 2 | 0.0247 |
| 8 | GO.0005643 | Nuclear pore | GO(STRING,V10) | 3 | 1.77E-005 |
| 9 | GO.0031080 | Nuclear pore outer ring | GO(STRING,V10) | 2 | 0.000493 |
| 10 | GO.0005635 | Nuclear envelope | GO(STRING,V10) | 3 | 0.00527 |
| 11 | GO.0000777 | Condensed chromosome kinetochore | GO(STRING,V10) | 2 | 0.0433 |
| 12 | GO.0000779 | Condensed chromosome, centromeric region | GO(STRING,V10) | 2 | 0.0433 |
FDR REPLACE, False Discovery Rate reported by STRING.